ArticleBMC cancer2021

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study.

Rui Kitadai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.